Climate change jeopardizes health care services, report says WASHINGTON (AP) — Dr. Suzy Fitzgerald remembers looking out the windows as wildfire flames surrounded the hospital where she worked. “We had fire in all three directions,” Fitzgerald recalled. AP NEWS

...

France's health body warns of resurgence of COVID virus in the country France's national health body warned on Friday of a resurgence of COVID-19 cases in the country, and urged people to continue to get vaccinated to protect themselves against the virus. Reuters Reuters

...

Africa CDC head: COVID still a threat given low vaccination rates The COVID-19 pandemic is still a threat on the African continent given low vaccination rates, the acting director of the Africa Centres for Disease Control and Prevention (Africa CDC) said on Thursday. Reuters Reuters

...

EU regulator backs wider use of AstraZeneca COVID therapy Europe's medicines regulator has backed using AstraZeneca's preventative COVID-19 therapy as a treatment for the disease and also endorsed another medicine as preventative option for another common virus. Pushkala Aripaka,Natalie Grover Reuters

...

HHS debuts ads for updated Covid-19 booster, focusing on adults 50 and older | CNN As part of the White House's Covid-19 response plan for the fall, the US Department of Health and Human Services is debuting a video ad to encourage people to get the updated Covid-19 booster shot -- especially those who are 50 and older. Jacqueline Howard CNN

...

US warns monkeypox could mutate to resist antiviral drug WASHINGTON (AP) — U.S. health officials are warning against overuse of the lone drug available to treat monkeypox, saying that even a small mutation in the virus could render the pills ineffective. AP NEWS

The Food and Drug Administration updated its guidance this week for Tpoxx, which has been prescribed to tens of thousands of patients with the virus.

...

Nearly 23,000 cases of monkeypox have been identified across the United States as of Sept. 14, Walensky told reporters.

"Over the last several weeks, we've been pleased to see a decline in the growth of new cases here and abroad. There are areas of the U.S. where the rate of rise in new cases is still increasing," she said. "We approach this news with cautious optimism."

...

Pfizer starts late-stage trial of mRNA-based flu vaccine Pfizer Inc said on Wednesday it had started a late-stage U.S. trial of an influenza vaccine involving 25,000 patients, among the first such studies for a messenger RNA flu shot. Reuters Reuters

...

German COVID booster take-up low, new version may help - doctors group Demand for booster vaccinations against COVID-19 is low in Germany, the association of general practitioners said on Thursday, with some patients waiting for a booster designed to combat the currently circulating Omicron BA.4/5 subvariants. Reuters Reuters

...

Complexity of Covid vaccine program leads to concerns about potential for error The rollout of the Covid-19 vaccination program has reached new heights of complexity with the start of the bivalent booster program, leading to concerns about the potential for more errors in the administration of vaccines. Helen Branswell STAT

...